- Home
- SSB vs BMRN Comparison
SSB vs BMRN Comparison
Compare SSB & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SSB | BMRN |
|---|---|---|
| Founded | 1933 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.6B | 10.0B |
| IPO Year | 2008 | 1999 |
Fundamental Metrics
Financial Performance| Metric | SSB | BMRN |
|---|---|---|
| Price | $99.77 | $60.25 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 16 |
| Target Price | ★ $118.92 | $87.94 |
| AVG Volume (30 Days) | 845.3K | ★ 2.2M |
| Earning Date | 04-23-2026 | 05-21-2026 |
| Dividend Yield | ★ 2.43% | N/A |
| EPS Growth | ★ 12.91 | N/A |
| EPS | ★ 7.87 | 1.80 |
| Revenue | N/A | ★ $1,313,646,000.00 |
| Revenue This Year | $9.63 | $11.04 |
| Revenue Next Year | $6.37 | $9.25 |
| P/E Ratio | ★ $12.52 | $34.29 |
| Revenue Growth | N/A | ★ 17.62 |
| 52 Week Low | $77.74 | $50.76 |
| 52 Week High | $108.46 | $73.51 |
Technical Indicators
Market Signals| Indicator | SSB | BMRN |
|---|---|---|
| Relative Strength Index (RSI) | 44.50 | 51.40 |
| Support Level | $99.00 | $56.08 |
| Resistance Level | $100.26 | $60.52 |
| Average True Range (ATR) | 3.43 | 2.62 |
| MACD | -0.80 | -0.09 |
| Stochastic Oscillator | 30.99 | 28.57 |
Price Performance
Historical ComparisonAbout SSB SouthState Corporation
SouthState Bank Corp is a United States-based bank holding company. It provides a wide range of services and products to its customers through a wholly-owned bank subsidiary. The Bank provides retail and commercial banking services, mortgage lending services, trust and investment services, and consumer finance loans through financial centers in Alabama, Florida, Georgia, North Carolina, South Carolina, and Virginia. These services include demand, time and savings deposits, lending and credit card servicing, ATM processing, and wealth management and trust services.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.